HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells

HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells

Previous research reported that the curcumin derivative (CU17) inhibited several cancer cell growths in vitro. However, its anticancer potential against human lung cancer cells (A549 cell lines) has not yet been evaluated. The purpose of this research was to examine the HDAC inhibitory and anti-canc...

Full description

Bibliographic Details
Main Authors: Narissara Namwan, Gulsiri Senawong, Chanokbhorn Phaosiri, Pakit Kumboonma, La-or Somsakeesit, Arunta Samankul, Chadaporn Leerat, Thanaset Senawong
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Molecules
Subjects:
apoptosis
cell cycle arrest
curcumin derivative
HDAC inhibitor
lung cancer
molecular docking
Online Access:https://www.mdpi.com/1420-3049/27/13/4014

Internet

https://www.mdpi.com/1420-3049/27/13/4014

Similar Items